Arrayit Corporation (ARYC)

[StockDetective]

My Arrayit Corp (ARYC) visit:

I spoke with Rene & Mark Schena face-to-face and also went hands on with their technology like many others have taken the time to do. I highly recommend it to anyone who has not done so already. I was impressed and this really boosted my confidence as a shareholder.

During the tour I was given the option for a free food intolerance test or an allergy test. I went with the allergy test. As I added my four drops of blood on the blood card, I observed hundreds of Pinnertests on the lab table waiting to be processed. If I had to guess, I would say roughly between 200-300 tests. I was told it was one days shipment... Now that’s Pinnertest alone and before all the big endorsements even came about.

Arrayit billing over $2 million per week now for the allergy fingerstick test alone?
Mark Schena stated, millions tested in the KTVU FOX media coverage last week!

https://www.ktvu.com/video/628515


Time to suit up, enter the clean room, & go hands on in the testing process...

Most of the equipment being used to process these test is reusable. Mass production would not be a problem for this company as robust machinery do most of the work.

I also asked about the OvaDx product and was advised that the details of the test were confidential at the time. As I pressed the issue a bit further was told that there was going to be a press release in the future regarding the matter. The subject was then changed as the good doctor advised me that he had said too much already.

When I finally viewed my allergy test report the name Dr Julie A. Taguchi showed up as the lab director of Arrayit. The report also comes with Arrayit’s CLIA laboratory number.

https://investorshub.advfn.com/uimage/uploads/2019/6/7/hyias84AA70FE-19A8-4E39-8F73-6FF2DB6E26D1.jpeg

arrayit_corporation So happy to have such an amazing Lab Director!

https://www.instagram.com/p/BdbQ7W7hzEy/

Dr Julie A. Taguchi is also described on the OvaDx product details down below...

Dr Julie A. Taguchi at Arrayit Corp announcing a sweet discovery?

https://www.instagram.com/p/BgMsxken3yb/

Dr Julie A. Taguchi discussion ovarian cancer:

This was from the old Arrayit website:

Can ovarian cancer be cured by early stage detection and treatment?

Yes. According to Dr. Julie A. Taguchi, MD, of the Sansum Medical Clinic in Santa Barbara, CA, surgical removal of stage IA ovarian tumors effectively cures ovarian cancer in a large percentage of patients without the requirement for chemotherapy. According to the medical literature, the 20-year survival rate for stage IA patients is very good.

http://www.arrayit.com/Microarray_Diagnostics/Ovarian_Cancer_Forum/ovarian_cancer_forum.html

This website was updated around mid 2018:

In Development

Arrayit Corporation and Avant Diagnostics, Inc. provide the market’s first large panel biomarker monitoring test for ovarian cancer (OVC). OvaDx® is advanced microarray-based test that measures the activation of the immune system in blood samples in response to early stage ovarian tumor cell development. Research studies with OvaDx® indicate high sensitivity and specificity for all types and stages of ovarian cancer including stage IA-IV borderline serous, clear cell, endometrioid, mixed epithelial, mucinous, serous, and ovarian adenocarcinoma. Upon FDA approval, Avant will offer OvaDx® as an elective test for women seeking greater wellness and for women in the elevated risk category for ovarian cancer. OvaDx® will be used by doctors to advance the forefront of ovarian cancer treatment including improved surgical options, more effective chemotherapies, and to supplement existing tests including CA-125, OVA1®, and transvaginal ultrasound.

Arrayit provides 7/2/18 FDA update: (1) excellent meeting, (2) large attendance by FDA top brass, (3) insightful and instructive, (4) our entire clinical team wishes to thank the agency for their feedback and generosity, and (5) we believe that our test will receive FDA approval.

https://mobile.twitter.com/arrayit

2019 newly updated Arrayit website:

Oncology

Advanced Cancer Detection

Microarray tests for ovarian cancer, colon cancer and other cancers measure the activation of the immune system in response to tumor cell development. Pre-symptomatic and early stage cancer detection improves patient prognosis and healthcare treatment options.

http://arrayit.com/